LINDSEY HALBROOK: Open Payments
NPI 1437721354 · DENVER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$963 in 36 payments from 18 companies in 2025. Trend: 2023 $256 · 2024 $436 · 2025 $963
Food & beverage: $963
| Company | Payments | Amount |
|---|---|---|
| SOBI, INC | 3 | $197 |
| ABBVIE INC. | 8 | $155 |
| Janssen Biotech, Inc. | 3 | $136 |
| Astellas Pharma US Inc | 3 | $55 |
| Incyte Corporation | 2 | $51 |
| Merck Sharp & Dohme LLC | 2 | $49 |
| Syndax Pharmaceuticals, Inc. | 2 | $48 |
| Daiichi Sankyo Inc. | 2 | $44 |
| PFIZER INC. | 2 | $35 |
| JAZZ PHARMACEUTICALS INC. | 1 | $28 |
Products named: Vonjo, TECVAYLI, EPKINLY, VENCLEXTA, JAKAFI, REVUFORJ, Vanflyta, Xospata.
Industry payments across CO — which companies pay providers there.
